Boxer Capital
18
37M
12
0.38
3
0.33
10
- Stages of investment
- Areas of investment
Summary
The company was established in North America in United States. The leading representative office of defined VC is situated in the Windermere.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Tavistock Life Sciences, startups are often financed by 5AM Ventures, Versant Ventures, Third Rock Ventures. The meaningful sponsors for the fund in investment in the same round are 5AM Ventures, Versant Ventures, Maverick Ventures. In the next rounds fund is usually obtained by Versant Ventures, 5AM Ventures, Maverick Ventures.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as E-Commerce, Health Care. Among the most popular portfolio startups of the fund, we may highlight Kalypsys, MethylGene, Ambrx. The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
Speaking about the real fund results, this VC is 1 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2015. The important activity for fund was in 2006. This Tavistock Life Sciences works on 7 percentage points more the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 18
- Lead investments
- 3
- Exits
- 10
- Rounds per year
- 0.38
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (18)
- Health Care (10)
- Biopharma (9)
- Therapeutics (9)
- Life Science (6) Show 9 more
- Investments by region
-
- United States (14)
- United Kingdom (1)
- Canada (2)
- Australia (1)
- Peak activity year
- 2006
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 91M
- Group Appearance index
- 1.00
- Avg. company exit year
- 11
- Avg. multiplicator
- 1.95
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Ambrx | 05 Jul 2006 | Biotechnology, Health Care, Life Science, Therapeutics, Biopharma | Late Stage Venture | 52M | United States, California, San Diego |
Kalypsys | 29 Nov 2006 | Biotechnology, Medical, Therapeutics | Late Stage Venture | 100M | United States, California, San Diego |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.